Skip to main content
PMC home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1993 Oct;101(5):372–377. doi: 10.1289/ehp.93101372

Medical hypothesis: xenoestrogens as preventable causes of breast cancer.

D L Davis 1, H L Bradlow 1, M Wolff 1, T Woodruff 1, D G Hoel 1, H Anton-Culver 1
PMCID: PMC1519851  PMID: 8119245

Abstract

Changes in documented risk factors for breast cancer and rates of screening cannot completely explain recent increases in incidence or mortality. Established risk factors for breast cancer, including genetics, account for at best 30% of cases. Most of these risk factors can be linked to total lifetime exposure to bioavailable estrogens. Experimental evidence reveals that compounds such as some chlorinated organics, polycyclic aromatic hydrocarbons (PAHs), triazine herbicides, and pharmaceuticals affect estrogen production and metabolism and thus function as xenoestrogens. Many of these xenoestrogenic compounds also experimentally induce mammary carcinogenesis. Recent epidemiologic studies have found that breast fat and serum lipids of women with breast cancer contain significantly elevated levels of some chlorinated organics compared with noncancer controls. As the proportion of inherited breast cancer in the population is small, most breast cancers are due to acquired mutations. Thus, the induction of breast cancer in the majority of cases stems from interactions between host factors, including genetics and environmental carcinogens. We hypothesize that substances such as xenoestrogens increase the risk of breast cancer by mechanisms which include interaction with breast-cancer susceptibility genes. A series of major epidemiologic studies need to be developed to evaluate this hypothesis, including studies of estrogen metabolism, the role of specific xenoestrogenic substances in breast cancer, and relevant genetic-environmental interactions. In addition, experimental studies are needed to evaluate biologic markers of suspect xenoestrogens and biologic markers of host susceptibility and identify pathways of estrogenicity that affect the development of breast cancer. If xenoestrogens do play a role in breast cancer, reductions in exposure will provide an opportunity for primary prevention of this growing disease.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
372

Images in this article

372p372-a
on p.372
375Figure 1.
on p.375

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartley J., Bartholomew J. C., Stampfer M. R. Metabolism of benzo(a)pyrene by human epithelial and fibroblastic cells: metabolite patterns and DNA adduct formation. J Cell Biochem. 1982;18(2):135–148. doi: 10.1002/jcb.1982.240180202. [DOI] [PubMed] [Google Scholar]
  2. Bertazzi P. A., Zocchetti C., Pesatori A. C., Guercilena S., Sanarico M., Radice L. Ten-year mortality study of the population involved in the Seveso incident in 1976. Am J Epidemiol. 1989 Jun;129(6):1187–1200. doi: 10.1093/oxfordjournals.aje.a115240. [DOI] [PubMed] [Google Scholar]
  3. Bradley C. J., Kledzik G. S., Meites J. Prolactin and estrogen dependency of rat mammary cancers at early and late stages of development. Cancer Res. 1976 Feb;36(2 Pt 1):319–324. [PubMed] [Google Scholar]
  4. Bradlow H. L., Michnovicz J., Telang N. T., Osborne M. P. Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice. Carcinogenesis. 1991 Sep;12(9):1571–1574. doi: 10.1093/carcin/12.9.1571. [DOI] [PubMed] [Google Scholar]
  5. Claus E. B., Risch N., Thompson W. D. Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet. 1991 Feb;48(2):232–242. [PMC free article] [PubMed] [Google Scholar]
  6. Coosen R., van Velsen F. L. Effects of the beta-isomer of hexachlorocyclohexane on estrogen-sensitive human mammary tumor cells. Toxicol Appl Pharmacol. 1989 Nov;101(2):310–318. doi: 10.1016/0041-008x(89)90279-2. [DOI] [PubMed] [Google Scholar]
  7. Dean A. G., Imrey H. H., Dusich K., Hall W. N. Adjusting morbidity ratios in two communities using risk factor prevalence in cases. Am J Epidemiol. 1988 Mar;127(3):654–662. doi: 10.1093/oxfordjournals.aje.a114840. [DOI] [PubMed] [Google Scholar]
  8. Donna A., Betta P. G., Robutti F., Crosignani P., Berrino F., Bellingeri D. Ovarian mesothelial tumors and herbicides: a case-control study. Carcinogenesis. 1984 Jul;5(7):941–942. doi: 10.1093/carcin/5.7.941. [DOI] [PubMed] [Google Scholar]
  9. Donna A., Crosignani P., Robutti F., Betta P. G., Bocca R., Mariani N., Ferrario F., Fissi R., Berrino F. Triazine herbicides and ovarian epithelial neoplasms. Scand J Work Environ Health. 1989 Feb;15(1):47–53. doi: 10.5271/sjweh.1882. [DOI] [PubMed] [Google Scholar]
  10. Dusich K., Sigurdson E., Hall W. N., Dean A. G. Cancer rates in a community exposed to low levels of creosote components in municipal water. Minn Med. 1980 Nov;63(11):803–806. [PubMed] [Google Scholar]
  11. Ekbom A., Trichopoulos D., Adami H. O., Hsieh C. C., Lan S. J. Evidence of prenatal influences on breast cancer risk. Lancet. 1992 Oct 24;340(8826):1015–1018. doi: 10.1016/0140-6736(92)93019-j. [DOI] [PubMed] [Google Scholar]
  12. Falck F., Jr, Ricci A., Jr, Wolff M. S., Godbold J., Deckers P. Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer. Arch Environ Health. 1992 Mar-Apr;47(2):143–146. [PubMed] [Google Scholar]
  13. Feuer E. J., Wun L. M. How much of the recent rise in breast cancer incidence can be explained by increases in mammography utilization? A dynamic population model approach. Am J Epidemiol. 1992 Dec 15;136(12):1423–1436. doi: 10.1093/oxfordjournals.aje.a116463. [DOI] [PubMed] [Google Scholar]
  14. Fishman J., Bradlow H. L. Effect of malnutrition on the metabolism of sex hormones in man. Clin Pharmacol Ther. 1977 Nov;22(5 Pt 2):721–728. doi: 10.1002/cpt1977225part2721. [DOI] [PubMed] [Google Scholar]
  15. Galbraith R. A., Michnovicz J. J. The effects of cimetidine on the oxidative metabolism of estradiol. N Engl J Med. 1989 Aug 3;321(5):269–274. doi: 10.1056/NEJM198908033210501. [DOI] [PubMed] [Google Scholar]
  16. Ghinea E., Dumitriu L., Stefanovici G., Pop A., Damian A., Handoca A., Stanciu R. Protein content and thyroid hormone release in vitro by differentiated thyroid cancer cells in the presence of estradiol, dehydroepiandrosterone, polypeptidic hormones and pesticides. Endocrinologie. 1988 Jul-Sep;26(3):165–171. [PubMed] [Google Scholar]
  17. Giwercman A., Skakkebaek N. E. The human testis--an organ at risk? Int J Androl. 1992 Oct;15(5):373–375. doi: 10.1111/j.1365-2605.1992.tb01351.x. [DOI] [PubMed] [Google Scholar]
  18. Griffith J., Duncan R. C., Riggan W. B., Pellom A. C. Cancer mortality in U.S. counties with hazardous waste sites and ground water pollution. Arch Environ Health. 1989 Mar-Apr;44(2):69–74. doi: 10.1080/00039896.1989.9934378. [DOI] [PubMed] [Google Scholar]
  19. HUGGINS C., YANG N. C. Induction and extinction of mammary cancer. A striking effect of hydrocarbons permits analysis of mechanisms of causes and cure of breast cancer. Science. 1962 Jul 27;137(3526):257–262. doi: 10.1126/science.137.3526.257. [DOI] [PubMed] [Google Scholar]
  20. Hahn R. A., Moolgavkar S. H. Nulliparity, decade of first birth, and breast cancer in Connecticut cohorts, 1855 to 1945: an ecological study. Am J Public Health. 1989 Nov;79(11):1503–1507. doi: 10.2105/ajph.79.11.1503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hall J. M., Lee M. K., Newman B., Morrow J. E., Anderson L. A., Huey B., King M. C. Linkage of early-onset familial breast cancer to chromosome 17q21. Science. 1990 Dec 21;250(4988):1684–1689. doi: 10.1126/science.2270482. [DOI] [PubMed] [Google Scholar]
  22. Hall N. E., Rosenman K. D. Cancer by industry: analysis of a population-based cancer registry with an emphasis on blue-collar workers. Am J Ind Med. 1991;19(2):145–159. doi: 10.1002/ajim.4700190203. [DOI] [PubMed] [Google Scholar]
  23. Harris J. R., Lippman M. E., Veronesi U., Willett W. Breast cancer (1) N Engl J Med. 1992 Jul 30;327(5):319–328. doi: 10.1056/NEJM199207303270505. [DOI] [PubMed] [Google Scholar]
  24. Henderson B. E., Ross R. K., Pike M. C. Hormonal chemoprevention of cancer in women. Science. 1993 Jan 29;259(5095):633–638. doi: 10.1126/science.8381558. [DOI] [PubMed] [Google Scholar]
  25. Henderson B. E., Ross R. K., Pike M. C. Toward the primary prevention of cancer. Science. 1991 Nov 22;254(5035):1131–1138. doi: 10.1126/science.1957166. [DOI] [PubMed] [Google Scholar]
  26. Hoel D. G., Davis D. L., Miller A. B., Sondik E. J., Swerdlow A. J. Trends in cancer mortality in 15 industrialized countries, 1969-1986. J Natl Cancer Inst. 1992 Mar 4;84(5):313–320. doi: 10.1093/jnci/84.5.313. [DOI] [PubMed] [Google Scholar]
  27. Holm L. E., Nordevang E., Hjalmar M. L., Lidbrink E., Callmer E., Nilsson B. Treatment failure and dietary habits in women with breast cancer. J Natl Cancer Inst. 1993 Jan 6;85(1):32–36. doi: 10.1093/jnci/85.1.32. [DOI] [PubMed] [Google Scholar]
  28. Howe G. R., Hirohata T., Hislop T. G., Iscovich J. M., Yuan J. M., Katsouyanni K., Lubin F., Marubini E., Modan B., Rohan T. Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies. J Natl Cancer Inst. 1990 Apr 4;82(7):561–569. doi: 10.1093/jnci/82.7.561. [DOI] [PubMed] [Google Scholar]
  29. Hsieh C. C., Lan S. J., Ekbom A., Petridou E., Adami H. O., Trichopoulos D. Twin membership and breast cancer risk. Am J Epidemiol. 1992 Dec 1;136(11):1321–1326. doi: 10.1093/oxfordjournals.aje.a116444. [DOI] [PubMed] [Google Scholar]
  30. Johnson D. C., Sen M., Dey S. K. Differential effects of dichlorodiphenyltrichloroethane analogs, chlordecone, and 2,3,7,8-tetrachlorodibenzo-p-dioxin on establishment of pregnancy in the hypophysectomized rat. Proc Soc Exp Biol Med. 1992 Jan;199(1):42–48. doi: 10.3181/00379727-199-43326. [DOI] [PubMed] [Google Scholar]
  31. Key T. J., Pike M. C. The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol. 1988 Jan;24(1):29–43. doi: 10.1016/0277-5379(88)90173-3. [DOI] [PubMed] [Google Scholar]
  32. Khan S. U., Foster T. S. Residues of atrazine (2-chloro-4-ethylamino-6-isopropylamino-s-triazine)and its metabolities in chicken tissues. J Agric Food Chem. 1976 Jul-Aug;24(4):768–771. doi: 10.1021/jf60206a029. [DOI] [PubMed] [Google Scholar]
  33. King M. C. Breast cancer genes: how many, where and who are they? Nat Genet. 1992 Oct;2(2):89–90. doi: 10.1038/ng1092-89. [DOI] [PubMed] [Google Scholar]
  34. Kohlmeier L., Rehm J., Hoffmeister H. Lifestyle and trends in worldwide breast cancer rates. Ann N Y Acad Sci. 1990;609:259–268. doi: 10.1111/j.1749-6632.1990.tb32073.x. [DOI] [PubMed] [Google Scholar]
  35. Korach K. S., Sarver P., Chae K., McLachlan J. A., McKinney J. D. Estrogen receptor-binding activity of polychlorinated hydroxybiphenyls: conformationally restricted structural probes. Mol Pharmacol. 1988 Jan;33(1):120–126. [PubMed] [Google Scholar]
  36. Kuratsune M., Ikeda M., Nakamura Y., Hirohata T. A cohort study on mortality of "yusho" patients: a preliminary report. Princess Takamatsu Symp. 1987;18:61–66. [PubMed] [Google Scholar]
  37. Law J. C., Strong L. C., Chidambaram A., Ferrell R. E. A germ line mutation in exon 5 of the p53 gene in an extended cancer family. Cancer Res. 1991 Dec 1;51(23 Pt 1):6385–6387. [PubMed] [Google Scholar]
  38. Li F. P., Fraumeni J. F., Jr Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med. 1969 Oct;71(4):747–752. doi: 10.7326/0003-4819-71-4-747. [DOI] [PubMed] [Google Scholar]
  39. Maltoni C., Ciliberti A., Cotti G., Conti B., Belpoggi F. Benzene, an experimental multipotential carcinogen: results of the long-term bioassays performed at the Bologna Institute of Oncology. Environ Health Perspect. 1989 Jul;82:109–124. doi: 10.1289/ehp.8982109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Manz A., Berger J., Dwyer J. H., Flesch-Janys D., Nagel S., Waltsgott H. Cancer mortality among workers in chemical plant contaminated with dioxin. Lancet. 1991 Oct 19;338(8773):959–964. doi: 10.1016/0140-6736(91)91835-i. [DOI] [PubMed] [Google Scholar]
  41. Mussalo-Rauhamaa H., Häsänen E., Pyysalo H., Antervo K., Kauppila R., Pantzar P. Occurrence of beta-hexachlorocyclohexane in breast cancer patients. Cancer. 1990 Nov 15;66(10):2124–2128. doi: 10.1002/1097-0142(19901115)66:10<2124::aid-cncr2820661014>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  42. Narod S. A., Feunteun J., Lynch H. T., Watson P., Conway T., Lynch J., Lenoir G. M. Familial breast-ovarian cancer locus on chromosome 17q12-q23. Lancet. 1991 Jul 13;338(8759):82–83. doi: 10.1016/0140-6736(91)90076-2. [DOI] [PubMed] [Google Scholar]
  43. Nelson J. A. Effects of dichlorodiphenyltrichloroethane (DDT) analogs and polychlorinated biphenyl (PCB) mixtures on 17beta-(3H)estradiol binding to rat uterine receptor. Biochem Pharmacol. 1974 Jan 15;23(2):447–451. doi: 10.1016/0006-2952(74)90436-5. [DOI] [PubMed] [Google Scholar]
  44. Pintér A., Török G., Börzsönyi M., Surján A., Csík M., Kelecsényi Z., Kocsis Z. Long-term carcinogenicity bioassay of the herbicide atrazine in F344 rats. Neoplasma. 1990;37(5):533–544. [PubMed] [Google Scholar]
  45. Ponder B. Cancer. Gene losses in human tumours. Nature. 1988 Sep 29;335(6189):400–402. doi: 10.1038/335400a0. [DOI] [PubMed] [Google Scholar]
  46. Porter W. P., Hinsdill R., Fairbrother A., Olson L. J., Jaeger J., Yuill T., Bisgaard S., Hunter W. G., Nolan K. Toxicant-disease-environment interactions associated with suppression of immune system, growth, and reproduction. Science. 1984 Jun 1;224(4652):1014–1017. doi: 10.1126/science.6426058. [DOI] [PubMed] [Google Scholar]
  47. RANADIVE K. J., KARANDE K. A. STUDIES ON 1,2:5,6-DIBENZANTHRACENE INDUCED MAMMARY CARCINOGENESIS IN MICE. Br J Cancer. 1963 Jun;17:272–280. doi: 10.1038/bjc.1963.39. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. SNELL K. C., STEWART H. L. Pulmonary adenomatosis induced in DBA/2 mice by oral administration of dibenz[a,h]-anthracene. J Natl Cancer Inst. 1962 May;28:1043–1051. [PubMed] [Google Scholar]
  49. Sharpe R. M., Skakkebaek N. E. Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet. 1993 May 29;341(8857):1392–1395. doi: 10.1016/0140-6736(93)90953-e. [DOI] [PubMed] [Google Scholar]
  50. Smith S. A., Easton D. F., Evans D. G., Ponder B. A. Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nat Genet. 1992 Oct;2(2):128–131. doi: 10.1038/ng1092-128. [DOI] [PubMed] [Google Scholar]
  51. Soto A. M., Sonnenschein C. The role of estrogens on the proliferation of human breast tumor cells (MCF-7). J Steroid Biochem. 1985 Jul;23(1):87–94. doi: 10.1016/0022-4731(85)90265-1. [DOI] [PubMed] [Google Scholar]
  52. Spicer D. V., Pike M. C., Henderson B. E. Ovarian cancer and long-term tamoxifen in premenopausal women. Lancet. 1991 Jun 8;337(8754):1414–1414. doi: 10.1016/0140-6736(91)93096-r. [DOI] [PubMed] [Google Scholar]
  53. Srivastava S., Zou Z. Q., Pirollo K., Blattner W., Chang E. H. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature. 1990 Dec 20;348(6303):747–749. doi: 10.1038/348747a0. [DOI] [PubMed] [Google Scholar]
  54. Telang N. T., Suto A., Wong G. Y., Osborne M. P., Bradlow H. L. Induction by estrogen metabolite 16 alpha-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells. J Natl Cancer Inst. 1992 Apr 15;84(8):634–638. doi: 10.1093/jnci/84.8.634. [DOI] [PubMed] [Google Scholar]
  55. Trichopoulos D., Brown J., MacMahon B. Urine estrogens and breast cancer risk factors among post-menopausal women. Int J Cancer. 1987 Dec 15;40(6):721–725. doi: 10.1002/ijc.2910400602. [DOI] [PubMed] [Google Scholar]
  56. Unger M., Kiaer H., Blichert-Toft M., Olsen J., Clausen J. Organochlorine compounds in human breast fat from deceased with and without breast cancer and in a biopsy material from newly diagnosed patients undergoing breast surgery. Environ Res. 1984 Jun;34(1):24–28. doi: 10.1016/0013-9351(84)90072-0. [DOI] [PubMed] [Google Scholar]
  57. Wassermann M., Nogueira D. P., Tomatis L., Mirra A. P., Shibata H., Arie G., Cucos S., Wassermann D. Organochlorine compounds in neoplastic and adjacent apparently normal breast tissue. Bull Environ Contam Toxicol. 1976 Apr;15(4):478–484. doi: 10.1007/BF01685076. [DOI] [PubMed] [Google Scholar]
  58. Welch R. M., Levin W., Conney A. H. Estrogenic action of DDT and its analogs. Toxicol Appl Pharmacol. 1969 Mar;14(2):358–367. doi: 10.1016/0041-008x(69)90117-3. [DOI] [PubMed] [Google Scholar]
  59. Welsch C. W. Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Res. 1985 Aug;45(8):3415–3443. [PubMed] [Google Scholar]
  60. Westin J. B., Richter E. The Israeli breast-cancer anomaly. Ann N Y Acad Sci. 1990;609:269–279. doi: 10.1111/j.1749-6632.1990.tb32074.x. [DOI] [PubMed] [Google Scholar]
  61. Willett W. C., Stampfer M. J., Colditz G. A., Rosner B. A., Hennekens C. H., Speizer F. E. Dietary fat and the risk of breast cancer. N Engl J Med. 1987 Jan 1;316(1):22–28. doi: 10.1056/NEJM198701013160105. [DOI] [PubMed] [Google Scholar]
  62. Wolff M. S., Toniolo P. G., Lee E. W., Rivera M., Dubin N. Blood levels of organochlorine residues and risk of breast cancer. J Natl Cancer Inst. 1993 Apr 21;85(8):648–652. doi: 10.1093/jnci/85.8.648. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES